1. Home
  2. RGEN vs MTCH Comparison

RGEN vs MTCH Comparison

Compare RGEN & MTCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • MTCH
  • Stock Information
  • Founded
  • RGEN 1981
  • MTCH 1986
  • Country
  • RGEN United States
  • MTCH United States
  • Employees
  • RGEN N/A
  • MTCH N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • MTCH Computer Software: Programming Data Processing
  • Sector
  • RGEN Health Care
  • MTCH Technology
  • Exchange
  • RGEN Nasdaq
  • MTCH Nasdaq
  • Market Cap
  • RGEN 7.6B
  • MTCH 8.2B
  • IPO Year
  • RGEN N/A
  • MTCH 2015
  • Fundamental
  • Price
  • RGEN $156.55
  • MTCH $31.69
  • Analyst Decision
  • RGEN Buy
  • MTCH Buy
  • Analyst Count
  • RGEN 12
  • MTCH 20
  • Target Price
  • RGEN $187.44
  • MTCH $37.89
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • MTCH 4.5M
  • Earning Date
  • RGEN 02-19-2025
  • MTCH 01-28-2025
  • Dividend Yield
  • RGEN N/A
  • MTCH 0.60%
  • EPS Growth
  • RGEN N/A
  • MTCH 27.57
  • EPS
  • RGEN N/A
  • MTCH 2.24
  • Revenue
  • RGEN $633,513,000.00
  • MTCH $3,485,425,000.00
  • Revenue This Year
  • RGEN $2.28
  • MTCH $5.48
  • Revenue Next Year
  • RGEN $9.88
  • MTCH $1.01
  • P/E Ratio
  • RGEN N/A
  • MTCH $14.12
  • Revenue Growth
  • RGEN N/A
  • MTCH 6.12
  • 52 Week Low
  • RGEN $113.50
  • MTCH $27.66
  • 52 Week High
  • RGEN $211.13
  • MTCH $39.91
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • MTCH 45.35
  • Support Level
  • RGEN $149.15
  • MTCH $30.69
  • Resistance Level
  • RGEN $160.64
  • MTCH $33.80
  • Average True Range (ATR)
  • RGEN 5.96
  • MTCH 0.81
  • MACD
  • RGEN 0.91
  • MTCH -0.13
  • Stochastic Oscillator
  • RGEN 79.57
  • MTCH 31.75

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About MTCH Match Group Inc.

Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Hinge, BLK, Chispa, Match.com, OkCupid, PlentyOfFish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).

Share on Social Networks: